Compare Stocks: FEMY, QTEX, IINN, and RNXT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$1.76 +0.6%	$2.55	$1.67 ▼ $22.20	$14.66M	-2.16	92,280 shs	35,452 shs
IINN Inspira Technologies OXY B.H.N.	$1.58 -15.5%	$0.97	$0.34 ▼ $1.65	$56.80M	2.16	352,435 shs	12.50 million shs
QTEX Inspira Technologies OXY B.H.N.	$1.58	$0.98	$0.28 ▼ $3.85	$56.80M	4.23	21.87 million shs	8.39 million shs
RNXT RenovoRx	$1.15 -8.0%	$1.57	$0.70 ▼ $2.59	$56.41M	0.98	583,540 shs	942,365 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	-12.50%	-13.37%	-37.05%	-51.39%	-85.71%
IINN Inspira Technologies OXY B.H.N.	0.00%	+70.00%	+110.11%	+26.35%	+65.49%
QTEX Inspira Technologies OXY B.H.N.	-15.51%	+2.60%	+77.53%	+5.33%	+157,999,900.00%
RNXT RenovoRx	-2.34%	-14.97%	-28.98%	+47.06%	+12.61%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$1.76 +0.6%	$2.55	$1.67 ▼ $22.20	$14.66M	-2.16	92,280 shs	35,452 shs
IINN Inspira Technologies OXY B.H.N.	$1.58 -15.5%	$0.97	$0.34 ▼ $1.65	$56.80M	2.16	352,435 shs	12.50 million shs
QTEX Inspira Technologies OXY B.H.N.	$1.58	$0.98	$0.28 ▼ $3.85	$56.80M	4.23	21.87 million shs	8.39 million shs
RNXT RenovoRx	$1.15 -8.0%	$1.57	$0.70 ▼ $2.59	$56.41M	0.98	583,540 shs	942,365 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	-12.50%	-13.37%	-37.05%	-51.39%	-85.71%
IINN Inspira Technologies OXY B.H.N.	0.00%	+70.00%	+110.11%	+26.35%	+65.49%
QTEX Inspira Technologies OXY B.H.N.	-15.51%	+2.60%	+77.53%	+5.33%	+157,999,900.00%
RNXT RenovoRx	-2.34%	-14.97%	-28.98%	+47.06%	+12.61%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FEMY Femasys	2.50	Moderate Buy	$50.00	2,740.91% Upside
IINN Inspira Technologies OXY B.H.N.	1.00	Sell	N/A	N/A
QTEX Inspira Technologies OXY B.H.N.	1.00	Sell	N/A	N/A
RNXT RenovoRx	2.75	Moderate Buy	$8.50	639.13% Upside

Current Analyst Ratings Breakdown

Latest FEMY, QTEX, IINN, and RNXT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/9/2026	QTEX Inspira Technologies OXY B.H.N.	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
9/25/2026	QTEX Inspira Technologies OXY B.H.N.	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/2/2026	RNXT RenovoRx	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/24/2026	QTEX Inspira Technologies OXY B.H.N.	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
8/18/2026	RNXT RenovoRx	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/18/2026	FEMY Femasys	Lake Street Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$10.00
8/17/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/14/2026	FEMY Femasys	Maxim Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$10.00
7/31/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
7/17/2026	RNXT RenovoRx	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
7/16/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 10/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FEMY Femasys	$2.30M	6.41	N/A	N/A	$2.01 per share	0.88
IINN Inspira Technologies OXY B.H.N.	$289K	196.54	N/A	N/A	$0.06 per share	26.33
QTEX Inspira Technologies OXY B.H.N.	$1.55M	36.55	N/A	N/A	$0.06 per share	26.33
RNXT RenovoRx	$1.98M	26.26	N/A	N/A	$0.15 per share	7.67

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FEMY Femasys	-$18.63M	-$3.53	N/A	N/A	N/A	-534.36%	-225.97%	-74.68%	11/17/2026 (Estimated)
IINN Inspira Technologies OXY B.H.N.	-$13.22M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
QTEX Inspira Technologies OXY B.H.N.	-$13.22M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RNXT RenovoRx	-$11.17M	-$0.31	N/A	N/A	N/A	-621.71%	-135.11%	-101.91%	11/12/2026 (Estimated)

Latest FEMY, QTEX, IINN, and RNXT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/24/2026	Q2 2026	QTEX Inspira Technologies OXY B.H.N.	N/A	-$0.07	N/A	-$0.07	N/A	$0.78 million
8/14/2026	Q2 2026	FEMY Femasys	-$1.31	-$1.33	-$0.02	-$1.33	$0.73 million	$0.33 million
8/12/2026	Q2 2026	RNXT RenovoRx	-$0.0725	-$0.05	+$0.0225	-$0.06	$0.70 million	$0.91 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	N/A
QTEX Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	N/A
RNXT RenovoRx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FEMY Femasys	0.89	2.14	0.55
IINN Inspira Technologies OXY B.H.N.	0.08	1.56	1.30
QTEX Inspira Technologies OXY B.H.N.	0.12	2.00	1.62
RNXT RenovoRx	N/A	5.74	5.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FEMY Femasys	65.27%
IINN Inspira Technologies OXY B.H.N.	12.72%
QTEX Inspira Technologies OXY B.H.N.	12.72%
RNXT RenovoRx	3.10%

Insider Ownership

Company	Insider Ownership
FEMY Femasys	7.75%
IINN Inspira Technologies OXY B.H.N.	29.40%
QTEX Inspira Technologies OXY B.H.N.	29.40%
RNXT RenovoRx	9.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FEMY Femasys	54	8.38 million	7.73 million	Not Optionable
IINN Inspira Technologies OXY B.H.N.	20	35.95 million	25.38 million	Not Optionable
QTEX Inspira Technologies OXY B.H.N.	41	35.95 million	25.38 million	N/A
RNXT RenovoRx	17	45.13 million	40.89 million	Not Optionable

FEMY, QTEX, IINN, and RNXT Headlines

Recent News About These Companies

RenovoRx Advances TAMP into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial

October 8, 2026 | marketscreener.comM

RenovoRx Enrolls First Patient In UVM-Sponsored Pancreatic Cancer PRISM-TAMP Trial

October 8, 2026 | rttnews.com

RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial

October 7, 2026 | globenewswire.com

Medline (NASDAQ:MDLN) versus RenovoRx (NASDAQ:RNXT) Head-To-Head Comparison

October 5, 2026 | americanbankingnews.com

RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer

October 1, 2026 | globenewswire.com

RenovoRx, Inc. (NASDAQ:RNXT) Stock Short Interest Jumps 55.7%

October 1, 2026 | marketbeat.com

RenovoRx, Inc. (NASDAQ:RNXT) Short Interest Update

September 17, 2026 | marketbeat.com

RenovoRx HC Wainwright presentation to highlight RenovoCath growth and Phase III TIGeR-PaC timeline

September 2, 2026 | msn.com

RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th

September 2, 2026 | globenewswire.com

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced ...

August 25, 2026 | finance.yahoo.com

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform's Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

August 25, 2026 | globenewswire.com

RenovoRx (NASDAQ:RNXT) Gains Attention After Compliance Update

August 21, 2026 | kalkinemedia.comK

RenovoRx regains Nasdaq compliance

August 21, 2026 | msn.com

RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

August 21, 2026 | globenewswire.com

RenovoRx Regains Nasdaq Compliance on Minimum Bid Price

August 20, 2026 | tipranks.com

RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment

August 20, 2026 | globenewswire.com

RenovoRx (RNXT) Q2 2026 Earnings Call Transcript

August 12, 2026 | finance.yahoo.com

RenovoRx, Inc. (RNXT) Q2 FY2026 earnings call transcript

August 12, 2026 | finance.yahoo.com

RenovoRx, Inc. (RNXT) Reports Q2 Loss, Beats Revenue Estimates

August 12, 2026 | zacks.com

RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth

August 12, 2026 | markets.businessinsider.com

RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer

August 11, 2026 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEMY, QTEX, IINN, and RNXT Company Descriptions

Femasys NASDAQ:FEMY

$1.76 +0.01 (+0.57%)

Closing price 04:00 PM Eastern

Extended Trading

$1.76 0.00 (0.00%)

As of 07:48 PM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$1.58 -0.29 (-15.51%)

As of 10/12/2026

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

$1.58 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$1.53 -0.05 (-2.91%)

As of 07:59 PM Eastern

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

RenovoRx NASDAQ:RNXT

$1.15 -0.10 (-8.00%)

Closing price 04:00 PM Eastern

Extended Trading

$1.15 0.00 (0.00%)

As of 07:53 PM Eastern

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FEMY, QTEX, IINN, and RNXT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FEMY, QTEX, IINN, and RNXT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FEMY, QTEX, IINN, and RNXT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEMY, QTEX, IINN, and RNXT Company Descriptions

Femasys NASDAQ:FEMY

Inspira Technologies OXY B.H.N. NASDAQ:IINN

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

RenovoRx NASDAQ:RNXT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FEMY, QTEX, IINN, and RNXT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FEMY, QTEX, IINN, and RNXT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FEMY, QTEX, IINN, and RNXT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEMY, QTEX, IINN, and RNXT Company Descriptions

Femasys NASDAQ:FEMY

Inspira Technologies OXY B.H.N. NASDAQ:IINN

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

RenovoRx NASDAQ:RNXT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools